Montelukast
Montelukast is a pharmaceutical drug with 148 clinical trials. Currently 16 active trials ongoing. Historical success rate of 92.5%.
Success Metrics
Based on 98 completed trials
Phase Distribution
Phase Distribution
19
Early Stage
35
Mid Stage
72
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
89.9%
98 of 109 finished
10.1%
11 ended early
16
trials recruiting
148
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Does Montelukast Decrease Post Adenotonsillectomy Pain in Children
Premedication to Reduce Amivantamab Associated Infusion Related Reactions
A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma
Montelukast in Parkinson Disease
Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma
Clinical Trials (148)
Does Montelukast Decrease Post Adenotonsillectomy Pain in Children
Premedication to Reduce Amivantamab Associated Infusion Related Reactions
A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma
Montelukast in Parkinson Disease
Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma
Effect of Montelukast on Doxorubicin Induced Cardiotoxicity in Breast Cancer
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
SMART 2D: Study of Montelukast's Effects on Renal and Cardiovascular Health in Adolescents and Young Adults With Type 2 Diabetes
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial
Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease
Efficacy of Montelukast on STEMl Patients
A Study to Investigate Subcutaneous Isatuximab in Combination With Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
ACTIV-6: COVID-19 Study of Repurposed Medications
SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM
A Prospective Study to Investigate Safety and Tolerability of Shorter Infusion of Fabrazyme
Clinical Evaluation of Montelukast in Veterans With Gulf War Illness
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Montelukast vs Fluticasone
Targeting Leukotrienes in Kidney Disease
Effect of Montelukast on Kidney and Vascular Function in Type 1 Diabetes
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 148